Naari Pharma Private Limited - Company Profile

It is a pharma private limited company based in Bangalore, Karnataka, India, established in 1978.
1978 Bangalore, Karnataka, India Active
Last Updated:
Access Report
About Naari Pharma Private Limited

Naari Pharma Private Limited, a active private limited company, was established on 23 February 1978 in Bangalore, Karnataka, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U74899KA1978PTC142872. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹86.83 Cr and a paid-up capital of ₹2.70 Cr.

Formerly known as Indo Phyto Chemicals Private Limited. It upholds a compliant status. Employing 186 professional, Its leadership includes Hermann Osterwald (Nominee Director), Prithipal Singh Kochhar (Whole-Time Director), Pudhucode Radhakrishnan Kannan (Nominee Director). Past directors included Jagtaran Singh Kochhar, Alex Francis Fernandes, Anil Mohan Puri. It holds ₹104.50 Cr open charges and ₹185.45 Cr settled loans. Its latest AGM occurred on 12 August 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No.30, Galaxy, 1St Main Road Jp Nagar, Third Phase, Bangalore, Karnataka, 560078.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74899KA1978PTC142872

  • Registration Number

    142872

  • Incorporation Date

    23 February 1978

  • Authorized Capital

    ₹86.83 Cr

  • Paid-Up Capital

    ₹2.70 Cr

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 86.83 Cr
  • Paid Up Capital ₹ 2.70 Cr
  • Company Age 48 Year, 2 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 104.50 Cr
  • Satisfied Charges ₹ 185.45 Cr
  • Revenue Growth **** 17.72%
  • Profit Growth **** 149.28%
  • Ebitda **** 22.41%
  • Net Worth 29.14%
  • Total Assets -4.13%
Company report

Naari Pharma Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Naari Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Naari Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Hermann Osterwald Nominee Director 30 Sep 2020 Current
Prithipal Singh Kochhar Whole-Time Director 15 Apr 2015 Current
Pudhucode Radhakrishnan Kannan Nominee Director 24 Jul 2025 Current
Deepak Komaregowda Nominee Director 06 Dec 2019 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 30 Sep 2020 Past
Pramod Abcsdd Director 27 Jan 2016 Past
Pramod Abcsdd Director 12 Feb 2016 Past
Pramod Abcsdd Director 27 Jan 2016 Past
Pramod Abcsdd Director 26 Jan 2016 Past
Pramod Abcsdd Director 17 Apr 2010 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Naari Pharma.

Naari Pharma Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 17.72% increase. The company also saw a substantial improvement in profitability, with a 149.28% increase in profit. The company's net worth Soared by an impressive increase of 29.14%.

Naari Pharma revenue growth over time
Naari Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 17.72%
*******
*******
*******
*******
Revenue from Operations
*******
 18.63%
*******
*******
*******
*******
Total Assets
*******
 -4.13%
*******
*******
*******
*******
Profit or Loss
*******
 149.28%
*******
*******
*******
*******
Net Worth
*******
 29.14%
*******
*******
*******
*******
EBITDA
*******
 22.41%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Naari Pharma?

In 2024, Naari Pharma had a promoter holding of 74.40% and a public holding of 25.59%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹1,045,000,000.00

Satisfied Charges

₹1,854,475,000.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 44.50 Cr
  • Tata Capital Financial Services Limited : 30.00 Cr
  • Others : 30.00 Cr
Latest Charge Details
Date Lender Amount Status
05 May 2022 Tata Capital Financial Services Limited ₹2.00 Cr Open
27 Dec 2021 Tata Capital Financial Services Limited ₹4.00 Cr Open
30 Sep 2021 Hdfc Bank Limited ₹44.50 Cr Open
17 Feb 2020 Others ₹30.00 Cr Open
29 Nov 2019 Tata Capital Financial Services Limited ₹24.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Naari Pharma?

Naari Pharma has a workforce of 186 employees as of Mar 05, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Naari Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Naari Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Naari Pharma
Recent Activity within the Organization
  • Charges

    The activity A charge with Others of Rs. 30.00 Cr registered on 17 Feb 2020 with Charge ID 100330199 was modified on 21 Aug 2025. was completed.

  • Annual General Meeting

    The activity Naari Pharma Private Limited last Annual general meeting of members was held on 12 Aug 2025 as per latest MCA records. was completed.

  • Director Appointment

    The activity Pudhucode Radhakrishnan Kannan was appointed as a Nominee Director was appointed as a Nominee Director on 24 Jul 2025 & has been associated with this company since 9 months 18 days . was completed.

  • Balance Sheet

    Progress on Naari Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was documented.

  • Director Appointment

    The activity Prashanth Bhaskar was appointed as a Cfo was appointed as a Cfo on 09 Oct 2024 & has been associated with this company since 1 year 7 months . was completed.

  • Charges

    Progress on A charge registered on 27 Dec 2022 via Charge ID 100688889 with Others was fully satisfied on 21 Mar 2024. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Naari Pharma Private Limited?

The CIN of Naari Pharma Private Limited is U74899KA1978PTC142872.

Where is Naari Pharma Private Limited headquartered?

Naari Pharma Private Limited is headquartered at Plot No.30, Galaxy, 1St Main Road Jp Nagar, Third Phase, Bangalore, Karnataka, 560078.

When was Naari Pharma Private Limited incorporated?

Naari Pharma Private Limited was incorporated on 23 February 1978.

Who are the current directors of Naari Pharma Private Limited?

The current directors of Naari Pharma Private Limited are

What is the primary industry of Naari Pharma Private Limited?

The primary industry of Naari Pharma Private Limited is Manufacturing.

Is Naari Pharma Private Limited a listed company?

Naari Pharma Private Limited is unlisted.

What is the capital structure of Naari Pharma Private Limited?

The authorized capital of Naari Pharma Private Limited is ₹86.83 Cr, and the paid-up capital is ₹2.70 Cr.

What is the compliance status of Naari Pharma Private Limited?

The compliance status of Naari Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available